Robertson Douglas J, Stukel Therese A, Gottlieb Daniel J, Sutherland Jason M, Fisher Elliott S
Veterans Affairs Outcomes Group, Veterans Affairs Medical Center, White River Junction, Vermont 05009, USA.
Cancer. 2009 Feb 15;115(4):752-9. doi: 10.1002/cncr.24081.
Most estimates of short- and long-term survival after hepatic resection of colorectal cancer metastases are derived from surgical case series. For the current report, the authors used Medicare data to investigate operative mortality and long-term survival in a national sample and examined the factors associated with survival.
Data were analyzed from Medicare enrollees (age >or=65 years) who were admitted to hospital between January 1, 2000 and December 31, 2004 with a primary diagnosis of colorectal cancer with resection. The sample was restricted to patients who subsequently underwent hepatic resection for liver metastases. The Medicare Denominator File was used to determine operative mortality and long-term survival and the factors that were associated with those outcomes.
Of the 306,061 Medicare beneficiaries who were diagnosed with colorectal cancer, 3957 patients were identified who underwent hepatic resection for liver metastases. The crude 30-day and 90-day mortality rates were 4% and 8.2%, respectively, and the 5-year survival rate was 25.5%. Advancing age (hazards ratio [HR], 1.83; 95% confidence interval [95% CI], 1.32-2.53 for age >or=80 years vs ages 65-69 years), comorbid disease (HR, 1.40; 95% CI, 1.06-1.85 for Charlson >or=5 vs Charlson 0), and synchronous colon/hepatic resection (HR, 2.46; 95% CI, 1.89-3.20 for synchronous vs metachronous resection) were associated with worse 90-day mortality. Similarly, long-term mortality was associated with age (HR, 1.36; 95% CI, 1.18-1.56), comorbid disease (HR, 1.51; 95% CI, 1.36-1.69), and synchronous colon/hepatic resection (HR, 1.37; 95% CI, 1.24-1.51 for synchronous vs metachronous resection).
In this national study, short- and long-term survival was worse than that reported in surgical case series. Subgroups at high risk for worse outcomes include the extreme elderly and those undergoing synchronous colon and hepatic resection.
大多数关于结直肠癌肝转移灶切除术后短期和长期生存率的估计来自手术病例系列。在本报告中,作者使用医疗保险数据调查了全国样本中的手术死亡率和长期生存率,并研究了与生存相关的因素。
对2000年1月1日至2004年12月31日期间因原发性结直肠癌伴切除术而入院的医疗保险参保者(年龄≥65岁)的数据进行分析。样本仅限于随后因肝转移而接受肝切除术的患者。使用医疗保险分母文件来确定手术死亡率和长期生存率以及与这些结果相关的因素。
在306,061名被诊断为结直肠癌的医疗保险受益人中,有3957名患者因肝转移接受了肝切除术。30天和90天的粗死亡率分别为4%和8.2%,5年生存率为25.5%。高龄(风险比[HR],1.83;95%置信区间[95%CI],年龄≥80岁与65 - 69岁相比为1.32 - 2.53)、合并症(HR,1.40;95%CI,Charlson评分≥5与Charlson评分为0相比为1.06 - 1.85)以及同期结肠/肝切除术(HR,2.46;95%CI,同期与异时切除相比为1.89 - 3.20)与90天死亡率较高相关。同样,长期死亡率与年龄(HR,1.36;95%CI,1.18 - 1.56)、合并症(HR,1.51;95%CI,1.36 - 1.69)以及同期结肠/肝切除术(HR,1.37;95%CI,同期与异时切除相比为1.24 - 1.51)相关。
在这项全国性研究中,短期和长期生存率低于手术病例系列报告的生存率。预后较差的高危亚组包括高龄患者以及接受同期结肠和肝切除术的患者。